Sotera Health (NASDAQ:SHC) Given Average Rating of “Moderate Buy” by Brokerages

Sotera Health (NASDAQ:SHC) has been given a consensus rating of “Moderate Buy” by the seven brokerages that are currently covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $16.08.

Several research firms have recently commented on SHC. The Goldman Sachs Group assumed coverage on Sotera Health in a research report on Friday, December 6th. They set a “neutral” rating and a $14.00 price target for the company. Royal Bank of Canada restated an “outperform” rating and set a $17.00 target price on shares of Sotera Health in a report on Thursday, November 21st. Finally, Citigroup boosted their price target on shares of Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, November 6th.

Institutional Trading of Sotera Health

Hedge funds have recently added to or reduced their stakes in the company. Wedmont Private Capital increased its position in shares of Sotera Health by 6.5% in the 3rd quarter. Wedmont Private Capital now owns 10,915 shares of the company’s stock valued at $169,000 after purchasing an additional 664 shares during the last quarter. First Citizens Bank & Trust Co. increased its holdings in Sotera Health by 5.0% in the third quarter. First Citizens Bank & Trust Co. now owns 14,287 shares of the company’s stock valued at $239,000 after buying an additional 677 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its stake in Sotera Health by 2.1% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 51,940 shares of the company’s stock valued at $711,000 after buying an additional 1,047 shares in the last quarter. GAMMA Investing LLC lifted its holdings in Sotera Health by 37.5% during the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock worth $56,000 after buying an additional 1,121 shares during the last quarter. Finally, Blue Trust Inc. boosted its position in shares of Sotera Health by 164.3% during the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock worth $25,000 after acquiring an additional 1,140 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Stock Up 2.2 %

Shares of SHC opened at $13.95 on Tuesday. The company’s 50-day moving average price is $13.25 and its 200 day moving average price is $14.52. Sotera Health has a 12-month low of $10.71 and a 12-month high of $17.44. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. The firm has a market cap of $3.95 billion, a P/E ratio of 55.80 and a beta of 1.92.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). The company had revenue of $285.47 million during the quarter, compared to analysts’ expectations of $278.64 million. Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. Sotera Health’s revenue was up 8.5% on a year-over-year basis. During the same period last year, the firm posted $0.18 earnings per share. On average, sell-side analysts forecast that Sotera Health will post 0.61 earnings per share for the current year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.